Cargando…

The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy

BACKGROUND: The purpose of this study was to investigate the impact of histology on survival stratified by the Graded Prognostic Assessment (GPA) for non-small cell lung cancer (NSCLC) in a group of selected patients treated recently. METHODS: A total of 171 NSCLC patients with brain metastases trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Liang-Hua, Li, Guang, Zhang, Hong-Wei, Wang, Zhi-Yu, Dang, Jun, Zhang, Shuo, Yao, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944239/
https://www.ncbi.nlm.nih.gov/pubmed/27411944
http://dx.doi.org/10.1186/s13014-016-0667-x
_version_ 1782442734969159680
author Ma, Liang-Hua
Li, Guang
Zhang, Hong-Wei
Wang, Zhi-Yu
Dang, Jun
Zhang, Shuo
Yao, Lei
author_facet Ma, Liang-Hua
Li, Guang
Zhang, Hong-Wei
Wang, Zhi-Yu
Dang, Jun
Zhang, Shuo
Yao, Lei
author_sort Ma, Liang-Hua
collection PubMed
description BACKGROUND: The purpose of this study was to investigate the impact of histology on survival stratified by the Graded Prognostic Assessment (GPA) for non-small cell lung cancer (NSCLC) in a group of selected patients treated recently. METHODS: A total of 171 NSCLC patients with brain metastases treated by hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy between 2001 and 2011 were included. The GPA score was calculated for each patient. Tumor histologies were categorized into adenocarcinoma (ADCA) and non-ADCA. Median survival time (MST, in months) was calculated using the Kaplan-Meier method. The log-rank test was used to determine statistical differences. RESULTS: MSTs by histology were: ADCA 15 (n = 92) and non-ADCA 10 (n = 79) (p < 0.001). For all patients, the MSTs by GPA score were: GPA 3.5-4, 24; GPA 2.5-3, 15; GPA 1.5-2, 9 and GPA 0-1, 6 (p < 0.001). The histology of ADCA showed a statistically significant higher MST than non-ADCA for patients with GPA 2.5-4. For GPA 2.5-3, MSTs were: ADCA 18, non-ADCA 10 (p = 0.007); for GPA 3.5-4, MSTs were: ADCA 30, non-ADCA 17 (p = 0.046). For GPA 0-2, MSTs did not differ significantly by histology. For GPA 0-1, MSTs were: ADCA 8, non-ADCA 4 (p = 0.146); GPA 1.5-2, MSTs were: ADCA 10, non-ADCA 8 (p = 0.291). We further found that non-ADCA in upper GPA class (3.5–4) had similar survival with ADCA in lower GPA class (2.5–3) (MSTs were 17 and 18, respectively, p = 0.775). This phenomenon also happened between patients of non-ADCA in upper GPA class (2.5–3) and those of ADCA in lower GPA class (1.5–2) (MSTs were both 10, p = 0.724). CONCLUSIONS: We confirmed that the histology of NSCLC had effect on the GPA in these selected patients treated recently. ADCA showed a statistically significant higher MST than non-ADCA with GPA 2.5-4. The non-ADCA in upper GPA classes (3.5-4 and 2.5-3) had similar survival to ADCA in lower GPA classes (2.5-3 and 1.5-2, respectively). The histology as a new factor should be added to the original GPA for NSCLC.
format Online
Article
Text
id pubmed-4944239
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49442392016-07-15 The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy Ma, Liang-Hua Li, Guang Zhang, Hong-Wei Wang, Zhi-Yu Dang, Jun Zhang, Shuo Yao, Lei Radiat Oncol Research BACKGROUND: The purpose of this study was to investigate the impact of histology on survival stratified by the Graded Prognostic Assessment (GPA) for non-small cell lung cancer (NSCLC) in a group of selected patients treated recently. METHODS: A total of 171 NSCLC patients with brain metastases treated by hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy between 2001 and 2011 were included. The GPA score was calculated for each patient. Tumor histologies were categorized into adenocarcinoma (ADCA) and non-ADCA. Median survival time (MST, in months) was calculated using the Kaplan-Meier method. The log-rank test was used to determine statistical differences. RESULTS: MSTs by histology were: ADCA 15 (n = 92) and non-ADCA 10 (n = 79) (p < 0.001). For all patients, the MSTs by GPA score were: GPA 3.5-4, 24; GPA 2.5-3, 15; GPA 1.5-2, 9 and GPA 0-1, 6 (p < 0.001). The histology of ADCA showed a statistically significant higher MST than non-ADCA for patients with GPA 2.5-4. For GPA 2.5-3, MSTs were: ADCA 18, non-ADCA 10 (p = 0.007); for GPA 3.5-4, MSTs were: ADCA 30, non-ADCA 17 (p = 0.046). For GPA 0-2, MSTs did not differ significantly by histology. For GPA 0-1, MSTs were: ADCA 8, non-ADCA 4 (p = 0.146); GPA 1.5-2, MSTs were: ADCA 10, non-ADCA 8 (p = 0.291). We further found that non-ADCA in upper GPA class (3.5–4) had similar survival with ADCA in lower GPA class (2.5–3) (MSTs were 17 and 18, respectively, p = 0.775). This phenomenon also happened between patients of non-ADCA in upper GPA class (2.5–3) and those of ADCA in lower GPA class (1.5–2) (MSTs were both 10, p = 0.724). CONCLUSIONS: We confirmed that the histology of NSCLC had effect on the GPA in these selected patients treated recently. ADCA showed a statistically significant higher MST than non-ADCA with GPA 2.5-4. The non-ADCA in upper GPA classes (3.5-4 and 2.5-3) had similar survival to ADCA in lower GPA classes (2.5-3 and 1.5-2, respectively). The histology as a new factor should be added to the original GPA for NSCLC. BioMed Central 2016-07-13 /pmc/articles/PMC4944239/ /pubmed/27411944 http://dx.doi.org/10.1186/s13014-016-0667-x Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Ma, Liang-Hua
Li, Guang
Zhang, Hong-Wei
Wang, Zhi-Yu
Dang, Jun
Zhang, Shuo
Yao, Lei
The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title_full The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title_fullStr The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title_full_unstemmed The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title_short The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
title_sort effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944239/
https://www.ncbi.nlm.nih.gov/pubmed/27411944
http://dx.doi.org/10.1186/s13014-016-0667-x
work_keys_str_mv AT malianghua theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT liguang theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT zhanghongwei theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT wangzhiyu theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT dangjun theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT zhangshuo theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT yaolei theeffectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT malianghua effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT liguang effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT zhanghongwei effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT wangzhiyu effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT dangjun effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT zhangshuo effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy
AT yaolei effectofnonsmallcelllungcancerhistologyonsurvivalasmeasuredbythegradedprognosticassessmentinpatientswithbrainmetastasestreatedbyhypofractionatedstereotacticradiotherapy